Disclaimer: Compounded tirzepatide and sermorelin are prepared by a licensed 503A compounding pharmacy and have not been reviewed or approved by the FDA. Compounded medications are not the same as commercially available FDA-approved products. This content reflects my perspective as a pharmaceutical executive and founder and is not medical advice. Consult one of our licensed providers for personalized clinical guidance.
About eight months into running our weight loss program, I started noticing a pattern I did not like. Patients on tirzepatide were losing weight — exactly as the data predicted. But a subset were describing something that went beyond fat loss. They were losing strength. Recovery was slower. They said they felt lighter but not better.
That pattern is what led me to build the tirzepatide and sermorelin combination program. From a pharmaceutical standpoint, I could see what was happening and why. I was not going to keep watching it.
What the Science Says About Lean Mass Loss on GLP-1 Therapy
This is the part most weight loss programs skip, and I think it is the most important conversation to have before someone starts. I am not going to frame it as clinical guidance, but I can explain the pharmacology clearly.
When the body enters a sustained caloric deficit, it draws energy from stored sources. Fat is the primary target, but the body also converts muscle-derived amino acids to glucose through gluconeogenesis. When growth hormone is already declining with age and the anabolic environment is already compromised, the body has less capacity to preferentially burn fat and spare protein. More of what comes off is lean mass.
Our clinical team sees this pattern consistently: a meaningful share of the weight lost on GLP-1 therapy is lean tissue rather than fat, particularly in patients not engaged in structured resistance training. This is a GLP-1 class pattern, not a specific drug problem, and it is exactly what the sermorelin pairing is designed to address.
For the full protocol on protecting lean mass — protein targets, training requirements, the leucine threshold, our clinical team explains this in detail and our doctor blog covers it at The Protein and Resistance Training Protocol for GLP-1 Patients.
Why the Sermorelin Stack Makes Pharmacological Sense
Sermorelin works through the GHRH receptor on pituitary somatotrophs, stimulating GH release in the natural pulsatile pattern. GH then drives IGF-1 production in the liver, and IGF-1 activates the PI3K/Akt/mTOR pathway at muscle cells — the primary intracellular signal for muscle protein synthesis. During a caloric deficit, mTOR is suppressed by low nutrient availability and reduced insulin signaling. Sermorelin-driven IGF-1 elevation provides a compensatory anabolic signal that partially offsets that suppression.
The two mechanisms are orthogonal. Tirzepatide handles the energy intake and fat metabolism side through the GLP-1 and GIP pathways. Sermorelin handles tissue preservation through the GHRH/GH/IGF-1 axis. They don’t overlap; they complement each other.
For more on what sermorelin does and the realistic timeline, see What Patients Actually Report After 90 Days on Sermorelin. For the full tirzepatide mechanism and how it compares to semaglutide, see Tirzepatide vs Semaglutide: What the Data Shows.
What I Observe in Our Patient Population
Patients on the combination program consistently describe a different qualitative experience at the end of the weight loss phase than patients on tirzepatide alone. They feel stronger. They look leaner rather than just smaller. One patient three months into the stack described it as the difference between losing weight and actually changing his body. He had done a GLP-1-only protocol two years earlier and arrived at his target weight feeling depleted. On the combination, he arrived at the same weight feeling strong and recovered.
That matches what the mechanism predicts. It is what I observe consistently enough to have made the combination a formal offering rather than a case-by-case decision.
Why Lean Mass Protection Matters Beyond the Scale
Muscle is metabolically active tissue. It burns calories at rest and supports the resting metabolic rate that determines how sustainable weight maintenance will be. Patients who lose significant lean mass during a weight loss phase often arrive at a lower number on the scale with a slower metabolism and feel physically worse than expected. Building the combination program was my way of taking a longer view on the outcome.
A Note on the Regulatory Environment
Both compounded tirzepatide online and compounded sermorelin are prepared at our 503A pharmacy and have not been reviewed or approved by the FDA. The shortage-based pathway that permitted broad tirzepatide compounding ended in late 2024. The current operative framework is 503A patient-specific compounding with documented clinical justification at the prescription level. Our clinical team handles that documentation for every patient.
What the Program Costs
The first month of the tirzepatide and sermorelin stack is $349.99. Both medications are compounded at our 503A pharmacy and the program runs under physician oversight through our telehealth platform. Compared to medical weight loss clinics where tirzepatide alone is often $400–600 a month with separate fees for additional prescriptions, $349.99 for the full stack is materially more accessible.
The pricing is secondary to the clinical rationale. The question worth asking before any weight loss program is not just how much weight will be lost — it is what the body will look like and how it will function when the process is complete.
FAQ
Can tirzepatide and sermorelin be taken together? Our clinical team uses this combination intentionally. Tirzepatide works through GLP-1 and GIP receptor pathways. Sermorelin works through the GHRH receptor on the pituitary, driving GH and IGF-1 production through a completely separate mechanism. The two don’t conflict. Both are compounded medications that have not been reviewed by the FDA.
Does sermorelin help with weight loss? Sermorelin is not a primary weight loss therapy. It supports body composition by helping preserve lean muscle mass during a caloric deficit through GH-driven protein sparing and IGF-1 mediated anabolic signaling. Our clinical team evaluates each patient’s situation individually.
Why do patients lose muscle during weight loss? During sustained caloric deficit, the body converts muscle-derived amino acids to glucose through gluconeogenesis. mTOR suppression from low nutrient availability also reduces muscle protein synthesis. A meaningful share of weight lost on GLP-1 therapy comes from lean tissue. Sermorelin addresses this through the GH/IGF-1 axis.
How much does the stack cost? $349.99 for the first month at Precision Telemed, including both medications and physician oversight.
If you want to talk through whether this is right for you, our providers are available online. Start at www.precisiontelemed.com.
This post reflects my personal perspective as a pharmaceutical executive and founder. It is not medical advice and does not establish a provider-patient relationship. Compounded medications have not been reviewed by the FDA and are not the same as commercially available FDA-approved products. Please consult one of our licensed providers for personalized clinical guidance.
About the Author: JP Rius is the founder of Precision Telemed with a background in pharmaceutical commercial sales, operations, and trade. Over the past two years, his clinical team has served more than 5,000 patients across weight loss, hormone therapy, peptide therapy, and longevity programs. His perspective is shaped by the commercial, regulatory, and operational side of telehealth medicine.